O-170 in vitro xenogeneic ibmir is more aggressive than allogeneic and is mediated by classical and alternative complement pathways

Dietmar K. Abendroth,Laura deJong,Desiree Klöpfer,Angela Unger,Wolfgang Albrecht,Roberto Hernandez-Alejandro,Xiufeng Zheng,Marianne Beduhn,Aminah Shunnar,Dauglas Quan,Weiping Min,Rupert Oberhuber,Paul Hengster,Martin Hermann,Peter Obrist,Gabriele Werner-Felmayer,Ernst R. Werner,Raimund Margreiter,Gerald Brandacher,Manuel Maglione,Tanja Herrler,Anne Tischer,Andreas Meyer,Sergej Feiler,Sebastian Nowak,Peter Bartenstein,Marcus Hacker,Karl W. Jauch
2009-01-01
Abstract:Purpose: Intraportally transplanted islets provoke an instant blood-mediated inflammatory reaction (IBMIR), resulting in acute islet destruction. In a simplified in vitro model, we compared the mechanisms of IBMIR induced by human (allogeneic, A) and pig (xenogeneic, X) islets. Methods/Materials: 2,500IEQ were incubated with fresh non-anticoagulated human blood in petri dishes in an incubator-shaker (37°C, 100rpm). Clotting times were recorded. Levels of complement activation products (iC3b for common pathway and Bb for alternative pathway) and C-peptide were compared to dishes with blood alone at 5, 30 and 60min. At 60min, clots were fixed for immunofluorescent staining. The effect of 1.6mg/mL low molecular weight dextran sulfate was investigated. Results: Exposure of human and pig islets to human blood induced equally rapid clotting (A: 3:13+1:31min vs. X: 3:54+1:42, P=0.35; compared to blood alone: 46:25+16:23min, P<0.0001). In X, average porcine C-peptide levels increased from 118 to 627ng/mL between 5 and 60min, indicating islet cell lysis. In A, human C-peptide only increased from 41 to 64ng/mL (P<0.05). IgM and IgG binding were observed on pig but not on human islets. In X, supernatants released by clots at 30min contained 50% more iC3b, and 77% more Bb than controls. These increases were only 7% and 38% in A (P<0.05). Dextran sulfate completely prevented clotting and reduced iC3b and Bb to control levels. However, in X, it did not prevent antibody binding and porcine C-peptide release. Conclusion: Xenogeneic IBMIR was more aggressive than allogeneic IBMIR in an in vitro model of islets exposed to human blood. Dextran sulfate prevented complement activation through the alternative pathway, but did not prevent antibody binding to pig islets and C-peptide release, suggesting an important role for the classical pathway of complement activation.
What problem does this paper attempt to address?